Moderna (MRNA)

Working Capital Ratio

29.93%

Quarterly · Period ending:

MRNA logo

MRNA Working Capital Ratio

Latest reported36.93%
MRNA FY Working Capital Ratio (65.23% → 36.93%)
High-resolution chart · PNG

MRNA working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
36.9347%
41.6702%
39.6722%
32.9028%
28.1446%
26.0188%
62.0156%
68.3028%
54.566%
65.2255%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.